Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 47 (1) , 8-21
- https://doi.org/10.1016/s0006-3223(99)00092-x
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- 606: Clozapine: Elevation of membrane unsaturated lipid levels as a new mechanism of actionSchizophrenia Research, 1997
- Evaluation of Treatment-Resistant SchizophreniaSchizophrenia Bulletin, 1997
- Regulatory Functions of Phospholipase A2Critical Reviews in Immunology, 1997
- Increasing fish oil intake - any net benefits?Drug and Therapeutics Bulletin, 1996
- α‐Linolenic Acid Dietary Deficiency Alters Age‐Related Changes of Dopaminergic and Serotoninergic Neurotransmission in the Rat Frontal CortexJournal of Neurochemistry, 1996
- Lipoxygenation of Docosahexaenoic Acid by the Rat Pineal BodyJournal of Neurochemistry, 1994
- Characterization of the Influence of Unsaturated Free Fatty Acids on Brain GABA/Benzodiazepine Receptor Binding In VitroJournal of Neurochemistry, 1994
- Elevated plasma prostaglandin E2 levels in schizophreniaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Penicillin and essential fatty acid supplementation in schizophreniaProstaglandins and Medicine, 1979
- Absence of Rheumatoid Arthritis in Schizophrenia*Australian and New Zealand Journal of Medicine, 1974